GLP-1 Med Users See Drop in Recurrent Afib Events
(MedPage Today) — Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators of these drugs in 2015-2022…
News Article- Obesity drug coverage could lead to ‘substantial’ increase in Medicare spending
by Michael Monostra Fact Checked by Richard Smith from Endocrine Today/Healio NewsPublished April 25, 2025 According to findings from a microsimulation model, covering obesity medications under Medicare Part D is projected to significantly increase federal spending, estimated at $47.7 billion over ten years. While these drugs may reduce healthcare costs associated with obesity-related conditions, these savings are currently not […]